FI
MRNA icon

FormulaFolio Investments’s Moderna MRNA Stock Holding History

FormulaFolio Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$5K Hold
22
– – ﹤0.01% 349
2021
Q1 		$3K Sell
22
-3,075
-99% -$446K ﹤0.01% 380
2020
Q4 		$324K Buy
+3,097
New +$313K 0.01% 517

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

FormulaFolio Investments's MRNA Position: Q2 2021 in Review

FormulaFolio Investments held its Moderna (MRNA) position steady in Q2 2021 at 22 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #349.

FormulaFolio Investments first reported a position in MRNA in Q4 2020 and has held it in 3 quarters since. The position peaked at $324K in Q4 2020. 903 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • FormulaFolio Investments held 22 shares of Moderna worth $5K as of Q2 2021.
  • FormulaFolio Investments left its Moderna share count unchanged in Q2 2021.
  • Moderna made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #349 holding.
  • FormulaFolio Investments first reported a position in Moderna in Q4 2020 and has held it in 3 quarters since.
  • FormulaFolio Investments's Moderna position peaked at $324K in Q4 2020.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.